HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications
about
Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential RisksNotch, lipids, and endothelial cells.The role of sphingolipid signalling in diabetes‑associated pathologies (Review).Sphingosine 1-Phosphate and Atherosclerosis.Sphingosylphosphorylcholine inhibits macrophage adhesion to vascular smooth muscle cells.Sphingosine-1-Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca2+ Sensitivity and Na+/H+ Exchange and Mediates Protection by Ischemic Preconditioning.An engineered S1P chaperone attenuates hypertension and ischemic injury.Vascular protection by high-density lipoprotein-associated sphingosine-1-phosphate.Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate.Endurance training selectively increases high-density lipoprotein-bound sphingosine-1-phosphate in the plasma.ApoA-I/SR-BI modulates S1P/S1PR2-mediated inflammation through the PI3K/Akt signaling pathway in HUVECs.Quality Versus Quantity: Making HDL Great Again.
P2860
Q26738344-CC1A26F5-F4AD-403E-8F1F-0CFFB92870ABQ37684675-034DE374-1B13-42D6-BE05-E0084D5E74C0Q37711953-BAEE2291-64F5-4107-B441-626B060A94B2Q38654911-1F0F7279-FF76-4488-8FC9-89740BA83DD0Q41841237-9FD7B1CE-6CFB-49E5-9D3E-62EFCA00B4A0Q42746435-BA537E2F-E52D-4044-9C1C-D2099256A49EQ45423411-B3499664-4545-48C8-A92F-787AD653F4FDQ47288414-8B7974C1-9092-47BE-8C71-352322D15CFDQ47390287-DB2F5782-2996-4410-A74E-1CE29DC4D202Q48158764-FF0E0617-957E-4F85-9C3F-0558F1BCD92AQ50903029-4EF593D5-0A81-4E81-AA3E-28BFC44284ADQ54913102-CFF3B605-E39E-4025-B979-986C97E01085
P2860
HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
HDL-S1P: cardiovascular functi ...... , and therapeutic applications
@ast
HDL-S1P: cardiovascular functi ...... , and therapeutic applications
@en
HDL-S1P: cardiovascular functi ...... , and therapeutic applications
@nl
type
label
HDL-S1P: cardiovascular functi ...... , and therapeutic applications
@ast
HDL-S1P: cardiovascular functi ...... , and therapeutic applications
@en
HDL-S1P: cardiovascular functi ...... , and therapeutic applications
@nl
prefLabel
HDL-S1P: cardiovascular functi ...... , and therapeutic applications
@ast
HDL-S1P: cardiovascular functi ...... , and therapeutic applications
@en
HDL-S1P: cardiovascular functi ...... , and therapeutic applications
@nl
P2860
P3181
P356
P1476
HDL-S1P: cardiovascular functi ...... , and therapeutic applications
@en
P2093
Bodo Levkau
P2860
P3181
P356
10.3389/FPHAR.2015.00243
P407
P577
2015-01-01T00:00:00Z